Caballero, Editha R.
HRN: 22-86-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2023
CLINDAMYCIN 300MG (CAP)
04/20/2023
04/22/2023
PO
300mg
Q8
DM Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes